Home | Healthcare | GLP-1 Receptor Agonist Market Report by Product (Victoza, Ozempic, Trulicity, Bydureon, Saxenda, and Others), Route of Administration (Parenteral, Oral), Application (Type 2 Diabetes Mellitus, Obesity, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics, Online Pharmacies), and Region 2026-2034 Report Format: PDF+Excel | Report ID: SR112026A13049 Report Description Table of Contents Methodology Request Sample GLP-1 Receptor Agonist Market Size: The global GLP-1 receptor agonist market size reached USD 29.0 Billion in 2025
Consumer drug summaries report **around 46 lb (23%) over ~6 months** in adults with type 2 diabetes, with substantial individual variability
Across 48 weeks of treatment, participants showed continued weight loss without any measurable decrease in the medications biological activity
These patients are usually managed with joint help from cardiologists, even as the cardio-oncology sub-speciality continues to become popular [29, 30]
Our Tualatin team welcomes new and returning patients from Portland, Tigard, Sherwood, and surrounding communities at 18840 SW Boones Ferry Road, Suite 140
doi: 10.1016/j.yexcr.2011.01.010
